In-depth inference of transcriptional regulatory networks reveals NPM1 as a therapeutic ribosomal regulator in MYC-amplified medulloblastoma
Abstract Medulloblastoma (MB) is an aggressive pediatric brain tumor with distinct molecular heterogeneity. Identifying subtype-specific signatures within Group 3 and Group 4 remains challenging due to shared cytogenetic alterations and limitations of conventional differential gene expression analys...
Saved in:
Main Authors: | Tong Chen, Huiyao Chen, Mingyang Xia, Yunfei Liao, Hao Li, Xinran Dong, Yifeng Lin, Wenhao Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-024-00792-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting protein synthesis pathways in MYC-amplified medulloblastoma
by: Devendra Kumar, et al.
Published: (2025-01-01) -
NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling
by: Mikael S. Lindström
Published: (2011-01-01) -
Ferroptosis Transcriptional Regulation and Prognostic Impact in Medulloblastoma Subtypes Revealed by RNA-Seq
by: Christophe Desterke, et al.
Published: (2025-01-01) -
Clinical case – medulloblastoma
by: A. Kablytė, et al.
Published: (2018-03-01) -
Ribosomal Proteins in Ribosome Assembly
by: Brigitte Pertschy, et al.
Published: (2024-12-01)